- AMRX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3ASR Filing
Amneal Pharmaceuticals (AMRX) S-3ASRAutomatic shelf registration
Filed: 1 Mar 19, 4:28pm
Exhibit 23.3
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in this Registration Statement (FormS-3) and related Prospectus of Amneal Pharmaceuticals, Inc. for the registration of its securities and to the incorporation by reference therein of our report dated March 1, 2019, with respect to the consolidated financial statements of Amneal Pharmaceuticals, Inc., included in its Annual Report (Form10-K) for the year ended December 31, 2018, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP |
Iseline, New Jersey |
March 1, 2019 |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.